Trial results
AI generated results summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
According to the results reported on ClinicalTrials.gov, this trial (NCT06173687) enrolled 51 participants, with 45 completing the study and 6 not completing it. The trial was measuring the stability of electrical readings from a cochlear implant — specifically, how consistent the electrical signals were across the implant's electrode contacts (the small components that deliver sound signals) over an 8-week period. The reported data shows that the primary outcome measured something called "impedance" — this is essentially the resistance to electrical signals across the implant's 22 electrode contacts. The trial tracked how much this resistance varied from day to day over 8 weeks. The reported result was a median variation of 0.36 kOhm (kilohms, a unit of electrical resistance). In plain terms, this number represents the typical amount of day-to-day fluctuation in the electrical readings across the implant's contacts during the study period. No secondary outcome measure data appears to have been reported in the submitted results. These are the results as reported to ClinicalTrials.gov. They are not medical advice — always discuss what they mean for you with your doctor.
View full results on ClinicalTrials.gov ↗
These are the results as reported to ClinicalTrials.gov, not medical advice. Verify independently with the trial site and discuss what they mean for you with your doctor.
Hearing Loss Trial, Completed
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- You are 18 years old or older (there is no maximum age limit)
- You have a specific type of cochlear implant (CIC4-based) with one of three particular electrode types, and you have had it for at least 6 months
- You speak the language that will be used to test your hearing and speech understanding fluently, as confirmed by the research team
- You are willing and able to sign a consent form agreeing to take part
Who may not be able to join:
- You scored below 3 on a short quiz checking your ability to use digital/mobile devices
- You have a specific technical fault with part of your cochlear implant (confirm with trial site)
- You have other health conditions — such as significant vision problems or difficulty with hand movement — that would stop you from completing the study activities
- You are unwilling or unable to follow the study requirements as decided by the research team
- You work at the research site running this study, or are a close family member (spouse, parent, child, or sibling) of someone who does
- You are an employee of Cochlear (the company running the trial) or work for an organisation contracted by Cochlear for this study
- You are currently taking part in, or have taken part in another clinical trial involving an experimental drug or device in the last 30 days (unless it was another Cochlear study and the research team confirms it does not affect your eligibility)
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Australian sites
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
2 site(s) in Australia. Confirm current status and contact details directly with the trial site.
Primary endpoints
Impedance Measurements
Can't join this trial?
Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.